Author:
Elmusrati Areeg,Wang Justin,Wang Cun-Yu
Abstract
AbstractHead and neck squamous cell carcinoma (HNSCC), an aggressive malignancy, is characterized by high morbidity and low survival rates with limited therapeutic options outside of regional surgery, conventional cytotoxic chemotherapy, and irradiation. Increasing studies have supported the synergistic role of the tumor microenvironment (TME) in cancer advancement. The immune system, in particular, plays a key role in surveillance against the initiation, development, and progression of HNSCC. The understanding of how neoplastic cells evolve and evade the immune system whether through self-immunogenicity manipulation, or expression of immunosuppressive mediators, provides the foundation for the development of advanced therapies. Furthermore, the crosstalk between cancer cells and the host immune system have a detrimental effect on the TME promoting angiogenesis, proliferation, and metastasis. This review provides a recent insight into the role of the key inflammatory cells infiltrating the TME, with a focus on reviewing immunological principles related to HNSCC, as cancer immunosurveillance and immune escape, including a brief overview of current immunotherapeutic strategies and ongoing clinical trials.
Publisher
Springer Science and Business Media LLC
Reference161 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 68, 394–424 (2018).
2. Siegel, R., Miller, K. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).
3. Cleary, C. et al. Biological features of human papillomavirus-related head and neck cancers contributing to improved response. Clin. Oncol. 28, 467–474 (2016).
4. Warnakulasuriya, S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral. Oncol. 46, 407–410 (2010).
5. Fakhry, C. & D’Souza, G. Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral. Oncol. 49, 863–871 (2013).
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献